KELLI BRYANT: Open Payments
NPI 1912135427 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 32 payments from 11 companies in 2025. Trend: 2023 $762 · 2024 $490 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| ABBVIE INC. | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Exact Sciences Corporation | 3 | $59 |
| PFIZER INC. | 2 | $36 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, AIRSUPRA, VRAYLAR, Kerendia, The Cologuard Plus Collection Kit, BREZTRI, CRYSVITA, Wegovy.
Industry payments across GA — which companies pay providers there.
